Article
Resveratrol enhances HBV replication through activating Sirt1-PGC-1α-PPARα pathway
21 Apr 2016
Abstract excerpt
The population of hepatitis B combined with a number of metabolic disorders is increasing significantly. Resveratrol (RSV) has been used as a preclinical drug for the treatment of the metabolic disorders. However, the impact of RSV on HBV replication remains unknown. In this study, the HBV-expressing hepatocelluar carcinoma cell line and mouse model created by hydrodynamic injection of viral DNA were used. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
